Study ID: TVP-1012/PM103
Study Title
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Teva Identifier
- TVP-1012/PM103
ClinicalTrials.gov Identifier
- NCT01049984
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: Rasagiline | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 12/01/2009 - 10/01/2012
Phase
- Phase 4
Study Type
Interventional
